List of Tables
Table 1. Global Non-Receptor Tyrosine Kinase Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Non-Receptor Tyrosine Kinase Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Non-Receptor Tyrosine Kinase Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose) of Key Manufacturers (2020-2025)
Table 5. Global Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Non-Receptor Tyrosine Kinase Inhibitors Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Non-Receptor Tyrosine Kinase Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non-Receptor Tyrosine Kinase Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-Receptor Tyrosine Kinase Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Non-Receptor Tyrosine Kinase Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-Receptor Tyrosine Kinase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Receptor Tyrosine Kinase Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-Receptor Tyrosine Kinase Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Non-Receptor Tyrosine Kinase Inhibitors Sales by Region (2020-2025) & (K Dose)
Table 18. Global Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global Non-Receptor Tyrosine Kinase Inhibitors Sales by Region (2026-2031) & (K Dose)
Table 20. Global Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Non-Receptor Tyrosine Kinase Inhibitors Sales by Country (2020-2025) & (K Dose)
Table 27. North America Non-Receptor Tyrosine Kinase Inhibitors Sales by Country (2026-2031) & (K Dose)
Table 28. North America Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Non-Receptor Tyrosine Kinase Inhibitors Sales by Country (2020-2025) & (K Dose)
Table 32. Europe Non-Receptor Tyrosine Kinase Inhibitors Sales by Country (2026-2031) & (K Dose)
Table 33. Europe Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Non-Receptor Tyrosine Kinase Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Non-Receptor Tyrosine Kinase Inhibitors Sales by Region (2020-2025) & (K Dose)
Table 37. Asia Pacific Non-Receptor Tyrosine Kinase Inhibitors Sales by Region (2026-2031) & (K Dose)
Table 38. Asia Pacific Non-Receptor Tyrosine Kinase Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Non-Receptor Tyrosine Kinase Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Non-Receptor Tyrosine Kinase Inhibitors Sales by Country (2020-2025) & (K Dose)
Table 42. Latin America Non-Receptor Tyrosine Kinase Inhibitors Sales by Country (2026-2031) & (K Dose)
Table 43. Latin America Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Non-Receptor Tyrosine Kinase Inhibitors Sales by Country (2020-2025) & (K Dose)
Table 47. Middle East and Africa Non-Receptor Tyrosine Kinase Inhibitors Sales by Country (2026-2031) & (K Dose)
Table 48. Middle East and Africa Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Non-Receptor Tyrosine Kinase Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose) by Type (2020-2025)
Table 51. Global Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose) by Type (2026-2031)
Table 52. Global Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global Non-Receptor Tyrosine Kinase Inhibitors Price (US$/Dose) by Type (2020-2025)
Table 59. Global Non-Receptor Tyrosine Kinase Inhibitors Price (US$/Dose) by Type (2026-2031)
Table 60. Global Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose) by Application (2020-2025)
Table 61. Global Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose) by Application (2026-2031)
Table 62. Global Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global Non-Receptor Tyrosine Kinase Inhibitors Price (US$/Dose) by Application (2020-2025)
Table 69. Global Non-Receptor Tyrosine Kinase Inhibitors Price (US$/Dose) by Application (2026-2031)
Table 70. Novartis AG Company Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Novartis AG Non-Receptor Tyrosine Kinase Inhibitors Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. Eli Lilly and Company Company Information
Table 76. Eli Lilly and Company Description and Business Overview
Table 77. Eli Lilly and Company Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Eli Lilly and Company Non-Receptor Tyrosine Kinase Inhibitors Product
Table 79. Eli Lilly and Company Recent Developments/Updates
Table 80. Pfizer Inc. Company Information
Table 81. Pfizer Inc. Description and Business Overview
Table 82. Pfizer Inc. Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Pfizer Inc. Non-Receptor Tyrosine Kinase Inhibitors Product
Table 84. Pfizer Inc. Recent Developments/Updates
Table 85. Johnson & Johnson Company Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Johnson & Johnson Non-Receptor Tyrosine Kinase Inhibitors Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Bristol-Myers Squibb Company Company Information
Table 91. Bristol-Myers Squibb Company Description and Business Overview
Table 92. Bristol-Myers Squibb Company Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Bristol-Myers Squibb Company Non-Receptor Tyrosine Kinase Inhibitors Product
Table 94. Bristol-Myers Squibb Company Recent Developments/Updates
Table 95. AbbVie Inc. Company Information
Table 96. AbbVie Inc. Description and Business Overview
Table 97. AbbVie Inc. Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. AbbVie Inc. Non-Receptor Tyrosine Kinase Inhibitors Product
Table 99. AbbVie Inc. Recent Developments/Updates
Table 100. Bayer AG Company Information
Table 101. Bayer AG Description and Business Overview
Table 102. Bayer AG Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Bayer AG Non-Receptor Tyrosine Kinase Inhibitors Product
Table 104. Bayer AG Recent Developments/Updates
Table 105. AstraZeneca PLC Company Information
Table 106. AstraZeneca PLC Description and Business Overview
Table 107. AstraZeneca PLC Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. AstraZeneca PLC Non-Receptor Tyrosine Kinase Inhibitors Product
Table 109. AstraZeneca PLC Recent Developments/Updates
Table 110. Merck & Co., Inc. Company Information
Table 111. Merck & Co., Inc. Description and Business Overview
Table 112. Merck & Co., Inc. Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Merck & Co., Inc. Non-Receptor Tyrosine Kinase Inhibitors Product
Table 114. Merck & Co., Inc. Recent Developments/Updates
Table 115. Amgen Inc. Company Information
Table 116. Amgen Inc. Description and Business Overview
Table 117. Amgen Inc. Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Amgen Inc. Non-Receptor Tyrosine Kinase Inhibitors Product
Table 119. Amgen Inc. Recent Developments/Updates
Table 120. Zai Lab Limited Company Information
Table 121. Zai Lab Limited Description and Business Overview
Table 122. Zai Lab Limited Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Zai Lab Limited Non-Receptor Tyrosine Kinase Inhibitors Product
Table 124. Zai Lab Limited Recent Developments/Updates
Table 125. BeiGene Company Information
Table 126. BeiGene Description and Business Overview
Table 127. BeiGene Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. BeiGene Non-Receptor Tyrosine Kinase Inhibitors Product
Table 129. BeiGene Recent Developments/Updates
Table 130. Takeda Pharmaceutical Company Limited Company Information
Table 131. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 132. Takeda Pharmaceutical Company Limited Non-Receptor Tyrosine Kinase Inhibitors Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. Takeda Pharmaceutical Company Limited Non-Receptor Tyrosine Kinase Inhibitors Product
Table 134. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Non-Receptor Tyrosine Kinase Inhibitors Distributors List
Table 138. Non-Receptor Tyrosine Kinase Inhibitors Customers List
Table 139. Non-Receptor Tyrosine Kinase Inhibitors Market Trends
Table 140. Non-Receptor Tyrosine Kinase Inhibitors Market Drivers
Table 141. Non-Receptor Tyrosine Kinase Inhibitors Market Challenges
Table 142. Non-Receptor Tyrosine Kinase Inhibitors Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-Receptor Tyrosine Kinase Inhibitors
Figure 2. Global Non-Receptor Tyrosine Kinase Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-Receptor Tyrosine Kinase Inhibitors Market Share by Type: 2024 & 2031
Figure 4. mTOR Inhibitors Product Picture
Figure 5. RAF/MEK Inhibitors Product Picture
Figure 6. CDK Inhibitors Product Picture
Figure 7. Global Non-Receptor Tyrosine Kinase Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Non-Receptor Tyrosine Kinase Inhibitors Market Share by Application: 2024 & 2031
Figure 9. Cancer Treatment
Figure 10. Autoimmune Disorders
Figure 11. Organ Transplantation
Figure 12. Others
Figure 13. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Non-Receptor Tyrosine Kinase Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 15. Global Non-Receptor Tyrosine Kinase Inhibitors Sales (2020-2031) & (K Dose)
Figure 16. Global Non-Receptor Tyrosine Kinase Inhibitors Average Price (US$/Dose) & (2020-2031)
Figure 17. Non-Receptor Tyrosine Kinase Inhibitors Report Years Considered
Figure 18. Non-Receptor Tyrosine Kinase Inhibitors Sales Share by Manufacturers in 2024
Figure 19. Global Non-Receptor Tyrosine Kinase Inhibitors Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Non-Receptor Tyrosine Kinase Inhibitors Players: Market Share by Revenue in Non-Receptor Tyrosine Kinase Inhibitors in 2024
Figure 21. Non-Receptor Tyrosine Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Non-Receptor Tyrosine Kinase Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Country (2020-2031)
Figure 24. North America Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Country (2020-2031)
Figure 25. United States Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Country (2020-2031)
Figure 28. Europe Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Country (2020-2031)
Figure 29. Germany Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Region (2020-2031)
Figure 36. China Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Country (2020-2031)
Figure 44. Latin America Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Non-Receptor Tyrosine Kinase Inhibitors Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Non-Receptor Tyrosine Kinase Inhibitors Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Non-Receptor Tyrosine Kinase Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Non-Receptor Tyrosine Kinase Inhibitors by Type (2020-2031)
Figure 55. Global Revenue Market Share of Non-Receptor Tyrosine Kinase Inhibitors by Type (2020-2031)
Figure 56. Global Non-Receptor Tyrosine Kinase Inhibitors Price (US$/Dose) by Type (2020-2031)
Figure 57. Global Sales Market Share of Non-Receptor Tyrosine Kinase Inhibitors by Application (2020-2031)
Figure 58. Global Revenue Market Share of Non-Receptor Tyrosine Kinase Inhibitors by Application (2020-2031)
Figure 59. Global Non-Receptor Tyrosine Kinase Inhibitors Price (US$/Dose) by Application (2020-2031)
Figure 60. Non-Receptor Tyrosine Kinase Inhibitors Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
